Benzyl L-(+)-Mandelate>98.0%(GC)25g

3,6-Di(2-thienyl)-2,5-dihydropyrrolo[3,4-c]pyrrole-1,4-dione>95.0%(HPLC)(N)5g

LIMONIN, 95%, 5g

3-(((5-Chloro-3-ethylpyrazolo[1,5-a]pyrimidin-7-yl)amino)methyl)pyridine 1-oxide, 95%, 50mg

2-Bromo-4,5-difluorobenzoic Acid>98.0%(GC)(T)5g

2-(2-(Trifluoromethyl)pyridin-4-yl)acetic acid, 98%, 100mg

(2E)-1-(3-bromophenyl)-3-(2-fluorophenyl)prop-2-en-1-one, 95.0%, 2g

4-Cyano-3-(5,5-Dimethyl-[1,3,2]dioxaborinan-2-yl)-pyridine, 98+%, 5g

2-(3-ETHOXYCYCLOBUTYL)ETHANAMINE, 95.0%, 250mg

2,4,6-Trifluorobenzylamine, 95.0%, 25g

Phenoxytetrafluorobromoethane, 95.0%, 1g

2,6-Difluorophenylacetylene, 99.0%, 250mg

Obiettivo Plan Fluarex PLFi 20x/0.50 IOS corretto all'infinito. Distanza di lavoro 1,5 mm